Literature DB >> 12737327

Outcome in adults with juvenile idiopathic arthritis. Comparison of the DUTCH-AIMS2 between JIA and RA.

L N Bruinooge1, R El Moussaoui, E Taal, B A C Dijkmans, R M Van Soesbergen.   

Abstract

OBJECTIVES: To compare outcome in adult patients with JIA in childhood with outcome in young adults with RA and to evaluate the use of the DUTCH-AIMS2 in adult JIA patients
METHODS: A questionnaire containing the DUTCH-AIMS2 to assess health outcomes (answers ranging from 0-10: 0=best) was sent to 142 adults with JIA (18-40 years). These health outcomes were compared with those of 34 young RA patients (< or = 40 years) from former studies. The DUTCH-AIMS2 was tested for its reliability and validity in adult JIA patients.
RESULTS: The response rate was 71%. Disease duration of JIA patients (mean 19.2+/-9.5 years) was longer than in young RA patients (mean 7.8+/-5.3 years). RA patients scored worse than JIA patients in all health status areas with the exception of mobility. The mean health outcome scores were low for all groups (< or = 4.80). The internal consistency and the validity of the DUTCH-AIMS2 were satisfactory.
CONCLUSIONS: Overall, the health outcome of oligoarticular and polyarticular adult JIA and young RA patients was quite good. The DUTCH-AIMS2 can be used as an instrument in outcome studies in JIA patients.

Entities:  

Mesh:

Year:  2003        PMID: 12737327     DOI: 10.1080/03009740310000094

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  1 in total

1.  A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.

Authors:  Timothy Beukelman; Janneke Anink; Lillemor Berntson; Ciaran Duffy; Justine A Ellis; Mia Glerup; Jaime Guzman; Gerd Horneff; Lianne Kearsley-Fleet; Ariane Klein; Jens Klotsche; Bo Magnusson; Kirsten Minden; Jane E Munro; Martina Niewerth; Ellen Nordal; Nicolino Ruperto; Maria Jose Santos; Laura E Schanberg; Wendy Thomson; Lisette van Suijlekom-Smit; Nico Wulffraat; Kimme Hyrich
Journal:  Pediatr Rheumatol Online J       Date:  2017-04-19       Impact factor: 3.054

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.